What You Need To Know About The I-Mab Analyst Downgrade Today - Yahoo Canada Shine On

IMAB Stock  USD 1.07  0.03  2.73%   
About 62% of I Mab's investor base is looking to short. The analysis of the overall investor sentiment regarding I Mab suggests that many traders are alarmed. The current market sentiment, together with I Mab's historical and current headlines, can help investors time the market. In addition, many technical investors use I Mab stock news signals to limit their universe of possible portfolio assets.
  
What You Need To Know About The I-Mab Analyst Downgrade Today Yahoo Canada Shine On

Read at news.google.com
Google News at Macroaxis
  

I Mab Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards I Mab can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

I Mab Fundamental Analysis

We analyze I Mab's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of I Mab using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of I Mab based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Working Capital

Working Capital Comparative Analysis

I Mab is currently under evaluation in working capital category among its peers. Working Capital is a measure of company efficiency and operating liquidity. The working capital is usually calculated by subtracting Current Liabilities from Current Assets. It is an important indicator of the firm ability to continue its normal operations without additional debt obligations. .

I Mab Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with I Mab stock to make a market-neutral strategy. Peer analysis of I Mab could also be used in its relative valuation, which is a method of valuing I Mab by comparing valuation metrics with similar companies.

Peers

I Mab Related Equities

DSGNDesign Therapeutics   6.75   
0%
100.0%
AKROAkero Therapeutics   4.71   
0%
69.0%
FHTXFoghorn Therapeutics   2.62   
0%
38.0%
KRYSKrystal Biotech   2.47   
0%
36.0%
STTKShattuck Labs   1.83   
0%
27.0%
CGEMCullinan Oncology   1.18   
0%
17.0%
RVMDRevolution Medicines   0.98   
0%
14.0%
KYMRKymera Therapeutics   0.79   
0%
11.0%
IMVTImmunovant   0.25   
0%
3.0%
BPMCBlueprint Medicines   0.00   
0%
0%
GLUEMonte Rosa   0.00   
0%
0%
APLSApellis Pharmaceuticals   0.00   
0%
0%
ERASErasca   0.54   
8.0%
0%
LYELLyell Immunopharma   0.69   
10.0%
0%
NRIXNurix Therapeutics   1.80   
26.0%
0%
ASNDAscendis Pharma   2.65   
39.0%
0%

Complementary Tools for IMAB Stock analysis

When running I Mab's price analysis, check to measure I Mab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy I Mab is operating at the current time. Most of I Mab's value examination focuses on studying past and present price action to predict the probability of I Mab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move I Mab's price. Additionally, you may evaluate how the addition of I Mab to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities